Skip to main content
. 2005 Jul 22;5:87. doi: 10.1186/1471-2407-5-87

Table 1.

Patient characteristics

Number of patients N = 16
Age
 Median 59
 Range 36–73
Male:female 14:2
ECOG performance status
 0 6 37%
 1 8 50%
 2 2 13%
Disease status
 Primary metastatic 12 75%
 Locally-advanced 4 25%
Prior chemotherapy
 Uracil-tegafur 4 25%
 5-FU bolus + folinic acid 1 6%
 5-FU + cisplatin 4 25%
 Epirubicin + cisplatin + capecitabine 5 31%
 Epirubicin + doxorubicin + cisplatin 2 13%